Brimonidine Nitroso Impurity 2
Specifications
Product name
Brimonidine Nitroso Impurity 2
SRC CAT No
SRC-N014466
CAS No
NA
Mol.F.
C11H9BrN6O
Mol.Wt.
321.13 g/mol
Related CAS No.
NA
Inv Status
CUSTOM SYNTHESIS
Chemical Structure
Product Overview
Description
Chemical Name
N-(5-Bromoquinoxalin-6-yl)-N-(4,5-dihydro-1H-imidazol-2-yl)nitrous amide
HSN Code
38229010
Synonym
N.A
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Brimonidine is used to relieve redness in the eyes caused by minor eye irritations (such as smog, swimming, dust, or smoke).Brimonidine Nitroso Impurity 2 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Brimonidine Nitroso Impurity 2 CAS NO:NA chemically represented as N-(5-Bromoquinoxalin-6-yl)-N-(4,5-dihydro-1H-imidazol-2-yl)nitrous amide . Synchemia is the leading manufacturing and exporter of Brimonidine Nitroso Impurity 2 . We supply Brimonidine Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Share your requirement and our team will take it forward with
clarity, confidentiality, and technical precision.
Related Products
N-Nitroso Eltrombopag Impurity 3
| CAT No | SRC-N0141239 |
| CAS No | NA |
| Mol.F. | C13H11N3O4 |
| Mol.Wt. | 273.2 |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Eltrombopag Impurity 1
| CAT No | SRC-N0141240 |
| CAS No | NA |
| Mol.F. | C12H13N3O2 |
| Mol.Wt. | 231.3 |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Esomeprazole
| CAT No | SRC-N0141241 |
| CAS No | NA |
| Mol.F. | C17H18N4O4S |
| Mol.Wt. | 374.4 |
| INV STATUS | CUSTOM SYNTHESIS |
Esomeprazole Nitroso Impurity 1
| CAT No | SRC-N0141242 |
| CAS No | NA |
| Mol.F. | C8H7N3O2S |
| Mol.Wt. | 209.2 |
| INV STATUS | CUSTOM SYNTHESIS |
Esomeprazole Nitroso Impurity 2
| CAT No | SRC-N0141243 |
| CAS No | NA |
| Mol.F. | C17H18N4O3S |
| Mol.Wt. | 358.4 |
| INV STATUS | CUSTOM SYNTHESIS |
Esomeprazole Nitroso Impurity 3
| CAT No | SRC-N0141244 |
| CAS No | NA |
| Mol.F. | C18H22N4O4S |
| Mol.Wt. | 390.5 |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Desmethoxy Esomeprazole
| CAT No | SRC-N0141245 |
| CAS No | NA |
| Mol.F. | C16H16N4O3S |
| Mol.Wt. | 344.4 |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Omeprazole
| CAT No | SRC-N0141246 |
| CAS No | NA |
| Mol.F. | C17H18N4O4S |
| Mol.Wt. | 374.4 |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Omeprazole EP Impurity I
| CAT No | SRC-N0141247 |
| CAS No | NA |
| Mol.F. | C17H18N4O6S |
| Mol.Wt. | 406.4 |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Ciprofloxacin EP Impurity B | N-Nitroso Desfluoro Ciprofloxacin
| CAT No | SRC-N0141248 |
| CAS No | NA |
| Mol.F. | C17H18N4O4 |
| Mol.Wt. | 342.4 |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Ciprofloxacin EP Impurity C | N-Nitroso Ciprofloxacin Ethylenediamine Analog
| CAT No | SRC-N0141249 |
| CAS No | NA |
| Mol.F. | C15H15FN4O4 |
| Mol.Wt. | 334.3 |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Ciprofloxacin EP Impurity D
| CAT No | SRC-N0141250 |
| CAS No | NA |
| Mol.F. | C17H17ClN4O4 |
| Mol.Wt. | 376.8 |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Ciprofloxacin EP Impurity E
| CAT No | SRC-N0141251 |
| CAS No | NA |
| Mol.F. | C16H17FN4O2 |
| Mol.Wt. | 316.3 |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Ciprofloxacin EP Impurity F
| CAT No | SRC-N0141252 |
| CAS No | NA |
| Mol.F. | C17H18N4O5 |
| Mol.Wt. | 358.4 |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Diltiazem EP Impurity G
| CAT No | SRC-N0141253 |
| CAS No | NA |
| Mol.F. | C19H21N3O4S |
| Mol.Wt. | 387.5 |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Aripiprazole Bromobutoxyquinoline Impurity
| CAT No | SRC-N0141254 |
| CAS No | NA |
| Mol.F. | C13H15BrN2O3 |
| Mol.Wt. | 327.2 |
| INV STATUS | CUSTOM SYNTHESIS |